Canada Hedge fund plots takeout of IGM Biosciences, its third Bay Area biotech zombie deal in three months Last updated: July 2, 2025 4:25 am By Ron Leuty Share 0 Min Read Hedge fund plots takeout of IGM Biosciences, its third Bay Area biotech zombie deal in three months SHARE As another Bay Area company faces acquisition, industry insiders are left wondering: Is this the beginning of a consolidation trend? Share This Article Email Copy Link Print Previous Article Lixte Biotechnology: Navigating Volatility Amid a $5M Financing Crossroads Next Article Binance’s CZ Donates $10M in BNB to Buterin’s Biotech Mission SearchSearch FDA Voucher Reforms: A Golden Opportunity in Biotech Valuations Canada Now, Emirates Partners with Crypto to Introduce Cryptocurrency Payment Option, Here’s All You Need To Know – Travel And Tour World Canada Bitcoin tops US$118,000 for the first time, and keeps on going Canada Kraken investigating issue with XRP (XRP) funding gateway Canada XRP
